J
Jagsonpal Pharmaceuticals
209.79
J
Jagsonpal Pharmaceuticals
209.79
JAGSNPHARM Fundamentals
Company Valuation
Market Cap (₹ Cr.)
1,403
PE Ratio
33.10
PB Ratio
5.17
Dividend Yield
1.18%
ROE
23.07%
ROCE
28.06%
Book Value (₹)
41.14
Face Value (₹)
2.00
Analyse JAGSNPHARM with 12+ custom fundamentals and financial ratios.
Share Holding Pattern
| Held By | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Promoters | 67.78% | 67.65% | 67.54% | 67.39% | 67.89% |
| Domestic Institutional Investors (DII) | 0.00% | 0.05% | 0.09% | 0.15% | 0.22% |
| Foreign Institutional Investors (FII) | 2.10% | 2.18% | 2.12% | 2.12% | 2.44% |
| Public Investors | 20.94% | 24.26% | 21.13% | 21.20% | 20.73% |
| Government | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Promoters
Domestic Institutional Investors (DII)
Foreign Institutional Investors (FII)
Public Investors
Government
JAGSNPHARM Investment Returns
Short Term
1 Week
1 Month
3 Months
6 Months
9 Months
Long Term
1 Year
2 Years
3 Years
4 Years
5 Years
- In Short Term
- In Long term
1 Week
1 Month
3 Months
6 Months
9 Months
Create Wealth in Longterm with Weekly and Monthly SIP in Stocks.
Stock & Sector Information
Sector
Healthcare
Sub Sector
Pharmaceuticals
Company Classification
Microcap
BSE Scrip Code
507789
NSE Scrip Name
JAGSNPHARM
ISIN
INE048B01035



